Methocarbamol

ANDA 85180, held by Watson Labs. Methocarbamol.

As of Nov 14, 2026, ANDA 85180 (Methocarbamol), held by Watson Labs, was first approved by FDA on Aug 26, 1976, with 18 approved supplements and 0 published complete response letters.

First approved: Aug 26, 1976
Supplements approved: 18
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 19 submissions below

Date	Submission	Status	Documents
Aug 26, 1976	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Methocarbamol500MG · tablet;oral	Methocarbamol	Discontinued

All 19 submissions, including labeling and manufacturing supplements


Feb 1, 1999	Supplement 40Manufacturing	Approved	None posted
Feb 1, 1999	Supplement 39Manufacturing	Approved	None posted
Feb 1, 1999	Supplement 38Manufacturing	Approved	None posted
Oct 17, 1997	Supplement 37Manufacturing	Approved	None posted
Oct 17, 1997	Supplement 36Manufacturing	Approved	None posted
Oct 17, 1997	Supplement 35Manufacturing	Approved	None posted
Nov 22, 1991	Supplement 34Labeling	Approved	None posted
Feb 6, 1989	Supplement 33Manufacturing	Approved	None posted
Aug 16, 1988	Supplement 32Manufacturing	Approved	None posted
Aug 16, 1988	Supplement 31Manufacturing	Approved	None posted
Aug 16, 1988	Supplement 30Manufacturing	Approved	None posted
Aug 16, 1988	Supplement 29Manufacturing	Approved	None posted
Mar 11, 1988	Supplement 27Manufacturing	Approved	None posted
Jan 13, 1987	Supplement 23Manufacturing	Approved	None posted
Jun 2, 1986	Supplement 24Manufacturing	Approved	None posted
Jan 10, 1986	Supplement 22Manufacturing	Approved	None posted
Mar 26, 1985	Supplement 21Manufacturing	Approved	None posted
Jan 18, 1983	Supplement 15Manufacturing	Approved	None posted
Aug 26, 1976	Original application	Approved	None posted

Identifiers

Application: ANDA 85180
Drugs@FDA: Overview at FDA
Company: Watson Laboratories

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters